FDA Recalls Tizanidine Tablets Due to Potential Labeling Mixup
Aidapak Services is recalling Tizanidine HCl tablets because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a moderate severity score. The hazard is a labeling mixup, which is a minor labeling error that could lead to incorrect medication administration but does not involve a high-risk pathogen or immediate structural defect.
Plain-English summary
Aidapak Services, LLC is voluntarily recalling Tizanidine HCl tablets, 2 mg, NDC 55111017915. The recall is due to a labeling mixup where the Tizanidine tablets may be mislabeled as other prescription medications, including Ribavirin, Cyanocobalamin, Niacin, and Pantoprazole Sodium DR.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The specific lot codes and expiration dates for the affected Tizanidine tablets are: Pedigree AD21790_40 (EXP 5/1/2014), Pedigree AD46265_16 (EXP 5/15/2014), Pedigree W002663 (EXP 6/5/2014), and Pedigree AD73525_31 (EXP 5/30/2014).
Consumers and healthcare providers should check their inventory for these specific lot codes and expiration dates. If the product is found, it should be returned to the distributor or the FDA. Patients should consult their healthcare provider if they have questions about their medication.
The recalled product
- Product
- tiZANidine HCl Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 55111017915
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- tiZANidine HCl
- Tablet
- 2 mg has the following codes Pedigree: AD21790_40
- EXP: 5/1/2014
- Pedigree: AD46265_16
- EXP: 5/15/2014
- Pedigree: W002663
- EXP: 6/5/2014
- Pedigree: AD73525_31
- EXP: 5/30/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02